Bulgarian scientist Assoc. Prof. Dr. Nevena Ivanova, a lecturer at Burgas State University "Prof. Dr. Asen Zlatarov", shone on the international stage, presenting her significant scientific discovery at the world genetics forum - ASHG 2025, held in Boston, USA. According to an official announcement from the university in Burgas, Assoc. Prof. Ivanova was the only representative of Bulgaria included in the scientific program of the prestigious event.
The discovery, representing a first-of-its-kind achievement in world science, represents a significant contribution to the in-depth study of the human genome and the genetic mechanisms responsible for the development of rare diseases. The study describes a new, previously unknown mutation in the FGF23 gene, identified in a patient with an extremely rare hereditary disease - hyperphosphatemic variant of tumoral calcinosis, complicated by severe vascular aneurysms and thromboses.
In the halls of the congress, where scientific achievements are discussed with excitement, one could feel the tension and excitement. Dozens of scientists from all over the world had gathered to share their discoveries, but also to learn from the experience of their colleagues.
Assoc. Prof. Ivanova holds three clinical specialties - internal medicine, cardiology, and general medicine, which complement her scientific expertise. She joined the teaching staff of Burgas State University in 2024 and, as of this year, holds the academic position of "Associate Professor" in general medicine. Her competence in the field of medical genetics is further supported by a certified qualification from Harvard Medical School, where she was awarded twice for high academic achievements.
ASHG, the international forum in the field of human genetics, attracts thousands of participants from dozens of countries every year. Among the attending scientists are also representatives of leading universities such as Harvard, MIT, Stanford, Oxford, Cambridge, and Columbia. This year, among the lecturers was Prof. Francis Collins himself, director of the emblematic Human Genome Project.